Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Filson

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Translational Andrology and Urology|May 8, 2018
Quality of care and economic considerations of active surveillance of men with prostate cancerChristopher P Filson
Urology|July 31, 2013
Editorial commentChristopher P Filson, John M Hollingsworth
Cancer|February 6, 2020
Reply to Obesity and aggressive prostate cancer and the golden rule: Do not do to others what you do not want done to yourselfShreyas S Joshi, Christopher P Filson
Cancer|December 4, 2019
Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screeningShreyas S Joshi, Christopher P Filson
Urology|August 25, 2016
Author ReplyIlan J Safir, Christopher P Filson
The Journal of Urology|April 27, 2018
Editorial CommentMark A Henry, Christopher P Filson
JAMA Network Open|October 7, 2020
Association of State-Level Medicaid Expansion With Treatment of Patients With Higher-Risk Prostate CancerWen Liu, Michael Goodman, Christopher P Filson
Journal of Surgical Oncology|March 4, 2016
The importance of surgical margins in renal cell and urothelial carcinomasMehrdad Alemozaffar, Christopher P Filson, Viraj A Master
Cancer|March 27, 2018
Cost considerations for systemic therapy for patients with advanced genitourinary malignanciesMark A Henry, Andrew Leung, Christopher P Filson
Urologic Oncology|December 3, 2014
Contemporary, age-based trends in the incidence and management of patients with early-stage kidney cancerHung-Jui Tan, Christopher P Filson, Mark S Litwin
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Translational Andrology and Urology|May 8, 2018
Quality of care and economic considerations of active surveillance of men with prostate cancerChristopher P Filson
Urology|July 31, 2013
Editorial commentChristopher P Filson, John M Hollingsworth
Cancer|February 6, 2020
Reply to Obesity and aggressive prostate cancer and the golden rule: Do not do to others what you do not want done to yourselfShreyas S Joshi, Christopher P Filson
Cancer|December 4, 2019
Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screeningShreyas S Joshi, Christopher P Filson
Urology|August 25, 2016
Author ReplyIlan J Safir, Christopher P Filson
The Journal of Urology|April 27, 2018
Editorial CommentMark A Henry, Christopher P Filson
JAMA Network Open|October 7, 2020
Association of State-Level Medicaid Expansion With Treatment of Patients With Higher-Risk Prostate CancerWen Liu, Michael Goodman, Christopher P Filson
Journal of Surgical Oncology|March 4, 2016
The importance of surgical margins in renal cell and urothelial carcinomasMehrdad Alemozaffar, Christopher P Filson, Viraj A Master
Cancer|March 27, 2018
Cost considerations for systemic therapy for patients with advanced genitourinary malignanciesMark A Henry, Andrew Leung, Christopher P Filson
Urologic Oncology|December 3, 2014
Contemporary, age-based trends in the incidence and management of patients with early-stage kidney cancerHung-Jui Tan, Christopher P Filson, Mark S Litwin
Pageof 13